• OSR Health plans to issue up to $15 million in convertible notes instead of common stock under its fully exercised equity option.
• Discussions with a Korea-based investor cover milestone-based funding tranches, with closing targeted no later than December 31, 2026.
• Completion requires a definitive note agreement setting tranche terms and conversion prices.
• The equity option will be reinstated if the note purchase fails to close within 10 business days of the scheduled closing date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OSR Holdings Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202611061011ACCESSWRNAPR_____1248137) on November 06, 2026, and is solely responsible for the information contained therein.